Stock 4507 SHIONOGI & CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Shionogi & Co., Ltd.

Equities

4507

JP3347200002

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-25 am EDT 		5-day change 1st Jan Change
7,148 JPY -2.66% Intraday chart for Shionogi & Co., Ltd. +0.03% +5.15%
Apr. 19 Shionogi & Co Completes Cancellation of 10.84 Million Treasury Shares MT
Apr. 18 Shionogi & Co., Ltd. Announces New Data from the European Real-World Evidence Study of Fetroja®/F etcroja® (cefiderocol) CI

Business Summary

Shionogi & Co., Ltd. specializes in development, manufacturing and marketing of pharmaceutical products. The group's activity is organized around 3 families of products:

- prescription products: drugs for the treatment of cardiovascular and infectious diseases, diabetes, allergic reactions, etc.;

- OTC products: analgesic products, vitamins and tonics, etc.;

- diagnosis products: primarily for detection and treatment of cardiovascular diseases and immune system.

Number of employees: 5,680

Sales per Business

JPY in Million2022Weight2023Weight Delta
Pharmaceutical
100.0 %
335,138 100.0 % 426,684 100.0 % +27.32%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
48.7 %
113,589 33.9 % 207,777 48.7 % +82.92%
United Kingdom
40.9 %
184,202 55.0 % 174,706 40.9 % -5.16%
Other
4.1 %
15,587 4.7 % 17,670 4.1 % +13.36%
United States
3.8 %
14,322 4.3 % 16,247 3.8 % +13.44%
Europe
2.4 %
7,427 2.2 % 10,276 2.4 % +38.36%
North America
0.0 %
8 0.0 % 6 0.0 % -25.00%

Managers

Managers TitleAgeSince
Isao Teshirogi CEO
 Chief Executive Officer 64 82-03-31
Yuji Hosogai DFI
 Director of Finance/CFO - -
Yasuetsu Imune CTO
 Chief Tech/Sci/R&D Officer - -
John Keller CTO
 Chief Tech/Sci/R&D Officer - -
Takuko Sawada BRD
 Director/Board Member 69 77-03-31
Yoshinori Yurugi PRN
 Corporate Officer/Principal - -
Aki Ikehata LAW
 General Counsel - -
Hirofumi Nagadome HRO
 Human Resources Officer - -
Harumi Shimai SAM
 Sales & Marketing - -
Takeshi Shiota PRN
 Corporate Officer/Principal - 14-12-31

Members of the board

Members of the board TitleAgeSince
Hiroshi Ozaki BRD
 Director/Board Member 74 19-05-31
Isao Teshirogi CEO
 Chief Executive Officer 64 82-03-31
Takuko Sawada BRD
 Director/Board Member 69 77-03-31
Keiichi Ando BRD
 Director/Board Member 72 16-05-31
Fumi Takatsuki BRD
 Director/Board Member 48 20-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 296,544,065 262,150,439 ( 88.40 %) 20,053,452 ( 6.762 %) 88.40 %

Shareholders

NameEquities%Valuation
Sumitomo Life Insurance Co.
6.274 %
18,604,000 6.274 % 953 M ¥
Nomura Asset Management Co., Ltd.
6.206 %
18,403,900 6.206 % 942 M ¥
SHIONOGI & CO., LTD.
3.390 %
10,052,488 3.390 % 515 M ¥
Sumitomo Mitsui Banking Pension Fund
3.199 %
9,485,000 3.199 % 486 M ¥
Nikko Asset Management Co., Ltd.
3.014 %
8,938,400 3.014 % 458 M ¥
BlackRock Fund Advisors
3.012 %
8,931,960 3.012 % 457 M ¥
Nippon Life Insurance Co.
2.836 %
8,409,000 2.836 % 431 M ¥
PING AN INSURANCE (GROUP) COMPANY OF CHINA, LTD.
2.143 %
6,356,000 2.143 % 325 M ¥
BlackRock Japan Co. Ltd.
2.075 %
6,154,600 2.075 % 315 M ¥
SUMITOMO MITSUI FINANCIAL GROUP, INC.
1.550 %
4,595,000 1.550 % 235 M ¥
NameEquities%Valuation
Todd Asset Management LLC
0.0998 %
1,227,606 0.0998 % 16 M ¥
RhumbLine Advisers LP
0.002491 %
30,626 0.002491 % 391 217 ¥
PNC Investments LLC
0.000989 %
12,166 0.000989 % 155 408 ¥
GAMMA Investing LLC
0.000243 %
2,989 0.000243 % 38 181 ¥
Operose Advisors LLC
0.000042 %
518 0.000042 % 6 617 ¥

Holdings

NameEquities%Valuation
SHIONOGI & CO., LTD.
3.39%
 10,052,488 3.39% 514,762,880 $
SUMITOMO MITSUI FINANCIAL GROUP, INC.
0.12%
 1,643,810 0.12% 96,763,714 $
TOHO HOLDINGS CO., LTD.
4.58%
 3,500,000 4.58% 84,456,050 $
SUZUKEN CO., LTD.
2.13%
 1,656,696 2.13% 50,780,748 $
KISSEI PHARMACEUTICAL CO., LTD.
1.85%
 914,000 1.85% 21,348,508 $
MEDIPAL HOLDINGS CORPORATION
0.57%
 1,271,605 0.57% 19,492,700 $
KANEKA CORPORATION
0.40%
 266,600 0.40% 6,718,507 $
STEMRIM
2.93%
 1,800,000 2.93% 5,827,752 $
ONO PHARMACEUTICAL CO., LTD.
0.07%
 344,095 0.07% 5,580,502 $
SUMITOMO MITSUI TRUST HOLDINGS, INC.
0.03%
 210,420 0.03% 4,599,224 $

Company contact information

Shionogi & Co., Ltd.

3-1-8 Dosho-machi Chuo-Ku

541-0045, Osaka

+81 6 6202 2161

http://www.shionogi.co.jp
address Shionogi & Co., Ltd.(4507)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Ratings for Shionogi & Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
7,148 JPY
Average target price
7,721 JPY
Spread / Average Target
+8.01%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SHIONOGI & CO., LTD. Stock Shionogi & Co., Ltd.
+5.15% 13.42B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.17% 562B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.90% 322B
ABBVIE INC. Stock AbbVie Inc.
+7.95% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.45% 219B
NOVARTIS AG Stock Novartis AG
+6.04% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-10.51% 196B
PFIZER, INC. Stock Pfizer, Inc.
-12.26% 149B
AMGEN INC. Stock Amgen Inc.
-6.47% 146B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4507 Stock
  4. Company Shionogi & Co., Ltd.